Observational studyDeutsches Arzteblatt international2026
Colonoscopy Versus Fecal Occult Blood Test Versus No Screening: A Comparative Analysis of Long-Term Effects.
Observational study in Deutsches Arzteblatt international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) remains a leading cause of cancer-related death. Many of these deaths could be prevented by screening. The German screening program was updated in April 2025, enabling men and women aged 50 and above to choose between fecal immunochemical testing (FIT) once every two years or up to 2 screening colonoscopies (CS) at an interval of 10 years apart. In this study, we compare the expected long-term outcomes for these strategies as well as for a combination of the two, assuming that full use is made of the tests that are offered.
methodsWe used COSIMO, a validated multi-stage simulation model for CRC, to assess expected outcomes assuming full adherence for simulated cohorts of 100 000 men and women aged 50-85. We calculated and compared the expected cumulative numbers of CRC cases and CRC-related deaths with FIT-based screening, colonoscopy-based screening, and no screening.
resultsOn the assumption of full adherence, the two screening strategies yielded similar reductions of CRC case numbers (69% for FIT, 77% for CS) and deaths from CRC (82% for both). Even stronger reductions were found if CS at age 50 and 60 was followed by FIT at ages 70, 72, and 74 (81% reduction in CRC cases, 89% reduction in deaths from CRC).
conclusionThe two screening strategies currently offered in Germany are highly effective to a similar extent. Our analysis yields relevant information for informed choices between the alternative screening offers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.